US Stock MarketDetailed Quotes

DMTKQ DermTech

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 27 16:00 ET
34.96Market Cap0.00P/E (TTM)

DermTech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
10.58%3.85M
5.36%15.3M
31.06%3.92M
9.57%3.92M
-5.98%3.98M
-6.48%3.48M
22.64%14.52M
-5.40%2.99M
17.92%3.57M
35.72%4.23M
Operating revenue
10.58%3.85M
5.36%15.3M
31.06%3.92M
9.57%3.92M
-5.98%3.98M
-6.48%3.48M
22.64%14.52M
-5.40%2.99M
17.92%3.57M
35.72%4.23M
Cost of revenue
-18.03%3.13M
8.28%15.02M
4.00%3.48M
1.33%3.74M
21.36%3.97M
7.51%3.82M
31.30%13.87M
10.20%3.35M
27.47%3.69M
24.73%3.27M
Gross profit
307.27%713K
-57.34%276K
223.60%440K
242.15%172K
-99.17%8K
-309.76%-344K
-49.22%647K
-384.80%-356K
-191.67%-121K
93.94%960K
Operating expense
-33.06%21.22M
-12.45%104.02M
-29.21%20.19M
-31.43%19.98M
4.37%32.14M
4.43%31.7M
51.02%118.81M
7.70%28.52M
42.49%29.14M
72.98%30.79M
Selling and administrative expenses
-34.21%17.96M
-6.31%88.78M
-28.10%16.84M
-30.08%16.39M
18.32%28.25M
13.64%27.29M
51.83%94.76M
14.31%23.43M
46.26%23.44M
68.07%23.88M
-Selling and marketing expense
-49.30%7.82M
-23.31%45M
-38.06%8.42M
-44.48%8.12M
-13.12%13.03M
-0.17%15.42M
56.15%58.67M
2.01%13.6M
48.91%14.63M
89.72%15M
-General and administrative expense
-14.63%10.14M
21.32%43.78M
-14.31%8.42M
-6.15%8.26M
71.44%15.22M
38.50%11.88M
45.30%36.09M
37.19%9.83M
42.06%8.81M
40.90%8.88M
Research and development costs
-25.92%3.27M
-36.64%15.24M
-34.31%3.35M
-36.95%3.6M
-43.79%3.89M
-30.44%4.41M
47.91%24.05M
-14.91%5.1M
28.83%5.7M
92.40%6.92M
Operating profit
36.00%-20.51M
12.21%-103.74M
31.60%-19.75M
32.30%-19.81M
-7.70%-32.13M
-6.14%-32.05M
-52.67%-118.17M
-9.56%-28.88M
-44.01%-29.26M
-72.38%-29.83M
Net non-operating interest income expense
-36.32%498K
112.23%2.85M
2.96%660K
32.16%641K
412.08%763K
1,084.85%782K
788.08%1.34M
1,356.82%641K
1,176.32%485K
325.71%149K
Non-operating interest income
-36.32%498K
112.23%2.85M
2.96%660K
32.16%641K
412.08%763K
1,084.85%782K
788.08%1.34M
1,356.82%641K
1,176.32%485K
325.71%149K
Other net income (expense)
-96.45%5K
-93.33%1K
25.00%5K
-94.29%6K
-141.18%-7K
112.96%141K
-94.27%15K
-97.63%4K
-38.24%105K
Gain on sale of security
----
-96.45%5K
-93.33%1K
25.00%5K
-94.29%6K
-141.18%-7K
112.96%141K
-94.27%15K
-97.63%4K
-38.24%105K
Income before tax
36.01%-20.01M
13.54%-100.89M
32.36%-19.09M
33.39%-19.16M
-6.03%-31.36M
-3.86%-31.27M
-48.95%-116.68M
-8.33%-28.22M
-43.06%-28.77M
-72.96%-29.58M
Income tax
Net income
36.01%-20.01M
13.54%-100.89M
32.36%-19.09M
33.39%-19.16M
-6.03%-31.36M
-3.86%-31.27M
-48.95%-116.68M
-8.33%-28.22M
-43.06%-28.77M
-72.96%-29.58M
Net income continuous Operations
36.01%-20.01M
13.54%-100.89M
32.36%-19.09M
33.39%-19.16M
-6.03%-31.36M
-3.86%-31.27M
-48.95%-116.68M
-8.33%-28.22M
-43.06%-28.77M
-72.96%-29.58M
Minority interest income
Net income attributable to the parent company
36.01%-20.01M
13.54%-100.89M
32.36%-19.09M
33.39%-19.16M
-6.03%-31.36M
-3.86%-31.27M
-48.95%-116.68M
-8.33%-28.22M
-43.06%-28.77M
-72.96%-29.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
36.01%-20.01M
13.54%-100.89M
32.36%-19.09M
33.39%-19.16M
-6.03%-31.36M
-3.86%-31.27M
-48.95%-116.68M
-8.33%-28.22M
-43.06%-28.77M
-72.96%-29.58M
Basic earnings per share
43.14%-0.58
20.36%-3.09
39.78%-0.56
40.63%-0.57
0.00%-0.99
-0.99%-1.02
-43.17%-3.88
-5.68%-0.93
-41.18%-0.96
-67.80%-0.99
Diluted earnings per share
43.14%-0.58
20.36%-3.09
39.78%-0.56
40.63%-0.57
0.00%-0.99
-0.99%-1.02
-43.07%-3.88
-5.68%-0.93
-41.18%-0.96
-67.80%-0.99
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 10.58%3.85M5.36%15.3M31.06%3.92M9.57%3.92M-5.98%3.98M-6.48%3.48M22.64%14.52M-5.40%2.99M17.92%3.57M35.72%4.23M
Operating revenue 10.58%3.85M5.36%15.3M31.06%3.92M9.57%3.92M-5.98%3.98M-6.48%3.48M22.64%14.52M-5.40%2.99M17.92%3.57M35.72%4.23M
Cost of revenue -18.03%3.13M8.28%15.02M4.00%3.48M1.33%3.74M21.36%3.97M7.51%3.82M31.30%13.87M10.20%3.35M27.47%3.69M24.73%3.27M
Gross profit 307.27%713K-57.34%276K223.60%440K242.15%172K-99.17%8K-309.76%-344K-49.22%647K-384.80%-356K-191.67%-121K93.94%960K
Operating expense -33.06%21.22M-12.45%104.02M-29.21%20.19M-31.43%19.98M4.37%32.14M4.43%31.7M51.02%118.81M7.70%28.52M42.49%29.14M72.98%30.79M
Selling and administrative expenses -34.21%17.96M-6.31%88.78M-28.10%16.84M-30.08%16.39M18.32%28.25M13.64%27.29M51.83%94.76M14.31%23.43M46.26%23.44M68.07%23.88M
-Selling and marketing expense -49.30%7.82M-23.31%45M-38.06%8.42M-44.48%8.12M-13.12%13.03M-0.17%15.42M56.15%58.67M2.01%13.6M48.91%14.63M89.72%15M
-General and administrative expense -14.63%10.14M21.32%43.78M-14.31%8.42M-6.15%8.26M71.44%15.22M38.50%11.88M45.30%36.09M37.19%9.83M42.06%8.81M40.90%8.88M
Research and development costs -25.92%3.27M-36.64%15.24M-34.31%3.35M-36.95%3.6M-43.79%3.89M-30.44%4.41M47.91%24.05M-14.91%5.1M28.83%5.7M92.40%6.92M
Operating profit 36.00%-20.51M12.21%-103.74M31.60%-19.75M32.30%-19.81M-7.70%-32.13M-6.14%-32.05M-52.67%-118.17M-9.56%-28.88M-44.01%-29.26M-72.38%-29.83M
Net non-operating interest income expense -36.32%498K112.23%2.85M2.96%660K32.16%641K412.08%763K1,084.85%782K788.08%1.34M1,356.82%641K1,176.32%485K325.71%149K
Non-operating interest income -36.32%498K112.23%2.85M2.96%660K32.16%641K412.08%763K1,084.85%782K788.08%1.34M1,356.82%641K1,176.32%485K325.71%149K
Other net income (expense) -96.45%5K-93.33%1K25.00%5K-94.29%6K-141.18%-7K112.96%141K-94.27%15K-97.63%4K-38.24%105K
Gain on sale of security -----96.45%5K-93.33%1K25.00%5K-94.29%6K-141.18%-7K112.96%141K-94.27%15K-97.63%4K-38.24%105K
Income before tax 36.01%-20.01M13.54%-100.89M32.36%-19.09M33.39%-19.16M-6.03%-31.36M-3.86%-31.27M-48.95%-116.68M-8.33%-28.22M-43.06%-28.77M-72.96%-29.58M
Income tax
Net income 36.01%-20.01M13.54%-100.89M32.36%-19.09M33.39%-19.16M-6.03%-31.36M-3.86%-31.27M-48.95%-116.68M-8.33%-28.22M-43.06%-28.77M-72.96%-29.58M
Net income continuous Operations 36.01%-20.01M13.54%-100.89M32.36%-19.09M33.39%-19.16M-6.03%-31.36M-3.86%-31.27M-48.95%-116.68M-8.33%-28.22M-43.06%-28.77M-72.96%-29.58M
Minority interest income
Net income attributable to the parent company 36.01%-20.01M13.54%-100.89M32.36%-19.09M33.39%-19.16M-6.03%-31.36M-3.86%-31.27M-48.95%-116.68M-8.33%-28.22M-43.06%-28.77M-72.96%-29.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 36.01%-20.01M13.54%-100.89M32.36%-19.09M33.39%-19.16M-6.03%-31.36M-3.86%-31.27M-48.95%-116.68M-8.33%-28.22M-43.06%-28.77M-72.96%-29.58M
Basic earnings per share 43.14%-0.5820.36%-3.0939.78%-0.5640.63%-0.570.00%-0.99-0.99%-1.02-43.17%-3.88-5.68%-0.93-41.18%-0.96-67.80%-0.99
Diluted earnings per share 43.14%-0.5820.36%-3.0939.78%-0.5640.63%-0.570.00%-0.99-0.99%-1.02-43.07%-3.88-5.68%-0.93-41.18%-0.96-67.80%-0.99
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.